Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study

Figure 3

Kaplan–Meier survival curve comparing percentage CVD-free survival in patients who were anti-apoA-1-positive ( n  = 135) and anti-apoA-1-negative ( n  = 364) in their early disease sample. Time (x axis) measured in years. The number of subjects at risk at each time point was as follows: 499 at time 0, 275 at 10 years, 94 at 20 years and 27 at 30 years. anti-apoA-1, antibodies to apolipoprotein A-1; CVD, cardiovascular disease.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us